hydromorphone and Anemia, Sickle Cell

hydromorphone has been researched along with Anemia, Sickle Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chhunchha, P; Russo, K1
Febres-Aldana, CA; Hernandez Howard, L1
Coleman, P; Govani, R; Sandoval, M; Siddiqui, S; Todd, KH1
Myers-Phariss, S; Perlman, KM; Rhodes, JC1
Pegelow, CH1

Trials

1 trial(s) available for hydromorphone and Anemia, Sickle Cell

ArticleYear
Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
    Journal of pain & palliative care pharmacotherapy, 2013, Volume: 27, Issue:1

    Topics: Acute Pain; Adult; Analgesics, Opioid; Anemia, Sickle Cell; Combined Modality Therapy; Female; Humans; Hyaluronoglucosaminidase; Hydromorphone; Hypodermoclysis; Injections, Subcutaneous; Male; Middle Aged; Morphine; Pain Measurement; Patient Satisfaction; Pilot Projects; Recombinant Proteins

2013

Other Studies

4 other study(ies) available for hydromorphone and Anemia, Sickle Cell

ArticleYear
Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Journal of pain & palliative care pharmacotherapy, 2023, Volume: 37, Issue:2

    Topics: Analgesia, Patient-Controlled; Anemia, Sickle Cell; Humans; Hydromorphone; Pain; Pain Management; Retrospective Studies; Volatile Organic Compounds

2023
Fatal Sickling Triggered by Massive Foreign Particle Embolism: A Case Report of Unrecognized Indwelling Venous Catheter Drug Abuse in Sickle Cell Disease.
    The American journal of forensic medicine and pathology, 2018, Volume: 39, Issue:2

    Topics: Adult; Analgesics, Opioid; Anemia, Sickle Cell; Catheters, Indwelling; Fatal Outcome; Female; Foreign Bodies; Hemolysis; Humans; Hydromorphone; Opioid-Related Disorders; Pulmonary Embolism; Splenomegaly; Tablets

2018
A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis.
    Journal of emergency nursing, 2004, Volume: 30, Issue:5

    Topics: Anemia, Sickle Cell; Clinical Protocols; Emergency Service, Hospital; Humans; Hydromorphone; Meperidine; Pain; Pain Measurement; Patient Admission; Program Evaluation

2004
Survey of pain management therapy provided for children with sickle cell disease.
    Clinical pediatrics, 1992, Volume: 31, Issue:4

    Topics: Acetaminophen; Analgesics; Anemia, Sickle Cell; Child; Child, Preschool; Codeine; Drug Administration Schedule; Drug Combinations; Humans; Hydromorphone; Infant; Length of Stay; Meperidine; Morphine; Nalbuphine; Pain; Pain Management; Seizures

1992